Elevated levels of CHI3L1 have been associated with disease progression and tissue damage in multiple sclerosis, neuromyelitis optica, and HIV-associated dementia, making it a key player in these pathologies. This evidence concerns the gene CHI3L1 and neuromyelitis optica.